Position in INAB
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$35,568
New position
Shares Held
24,033
first reported quarter
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 19 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026OPPENHEIMER & CO INC holds $44,352,224 across 44 Biotechnology names. INAB ranks #41 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,477 | $17,366,629 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
150,133 | $4,885,327 | |
| 3 | TYRA |
Tyra Biosciences, Inc.
|
84,192 | $3,224,553 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
63,666 | $1,935,446 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,308 | $1,923,694 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
68,116 | $1,686,552 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
|
106,924 | $1,370,765 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
100,027 | $1,193,322 |
All Filings in INAB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,568 | 24,033 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||